Skip to main content
BrainCited

Uridine Monophosphate pour Neurotransmitter Imbalance

C

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Duridine\u002Dmonophosphate\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

Key Study Findings

Observational Study
Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation.
Dose: None vs: None Outcome: None Effet: None None

Population: Dogs with intervertebral disc herniation

In Vitro
The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites.
Dose: None vs: LPS-treated astrocyte controls Outcome: Astrocyte gene expression and metabolite changes Effet: None None

Population: LPS-induced inflammatory astrocyte model

Review
Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the …
Dose: None vs: None Outcome: None Effet: None None

Population: None

Other
1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora …
Dose: None vs: None Outcome: None Effet: None P = 0.013

Population: Healthy adults

Other 4 weeks
Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling …
Dose: 5 mg/kg vs: None Outcome: Cognitive function Effet: None None

Population: Sprague Dawley rats

Key Statistics

4

Études

300

Participants

Positive

C

Note

Referenced Papers

Aging and disease 2023 9 citations
Clinical pharmacokinetics 2018 128 citations
Autonomic neuroscience : … 2015 81 citations
European journal of … 2011 16 citations
Annual review of … 2009 141 citations
The European journal … 2007 55 citations
Journal of neuroscience … 1996 16 citations
Behavioural brain research 1995 146 citations
Journal of steroid … 1984 22 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
150-250 mg/day
cognitivesupport:
250-500 mg sublingually

Limite supérieure : Not established; well-tolerated up to 1,000 mg/day

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Neutral --
5 mg/kg 4 weeks Positive --
1 g -- Mixed --
None -- Mixed --
None -- Mixed --

Moment optimal de prise : Morning; synergizes with DHA and choline sources

Safety & Side Effects

Effets indésirables signalés

  • Mild gastrointestinal discomfort
  • Headache (rare)
  • Nervousness at high doses

Interactions connues

  • No significant drug interactions established

Apport maximal tolérable : Not established; well-tolerated up to 1,000 mg/day

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Uridine Monophosphate help with Neurotransmitter Imbalance?
Based on 4 studies with 300 participants, there is limited but promising evidence that Uridine Monophosphate may support Neurotransmitter Imbalance management. Our evidence grade is C (Some Evidence).
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 150-250 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Uridine Monophosphate?
Reported side effects may include Mild gastrointestinal discomfort, Headache (rare), Nervousness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

Autres ingrédients pour Neurotransmitter Imbalance

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.